Skip to main content
SAREUM HOLDINGS PLC logo

SAREUM HOLDINGS PLC — Investor Relations & Filings

Ticker · SAR ISIN · GB00BMC3RJ87 LEI · 213800PKERN2DY8FFM72 IL Manufacturing
Open in API
Filings indexed 348 across all filing types
Latest filing 2022-11-09 Regulatory Filings
Country GB United Kingdom
Listing IL SAR

About SAREUM HOLDINGS PLC

https://www.sareum.com/

Sareum Holdings PLC is a clinical-stage small molecule company that discovers and develops next-generation kinase inhibitors for the treatment of autoimmune diseases and cancer. The company's research is primarily focused on the TYK/JAK kinase cell signalling family, with a specific emphasis on developing dual inhibitors of TYK2 and JAK1. This approach is pursued for its potential to offer superior efficacy compared to agents that target only one of these kinases. Its development pipeline includes SDC-1801, a potential oral therapy for autoimmune diseases, as well as other programs targeting cancer and viral infections.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document explicitly starts with 'RNS Number' and contains information about a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. It concludes by stating that the information is provided by RNS, the news service of the London Stock Exchange, which is approved as a Primary Information Provider. This structure and content strongly indicate a general regulatory announcement or market notice, which fits best under the 'Regulatory Filings' category (RNS), as it is not a specific financial report, management change, or shareholder vote result.
2022-11-09 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1920 characters) and its primary content is an announcement regarding a 'Price Monitoring Extension' for a security on the London Stock Exchange, identified by an 'RNS Number'. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement that doesn't fit the highly specific categories (like DIRS, DIV, or MANG), the most appropriate classification is the general regulatory filing fallback category.
2022-11-09 English
Second Price Monitoring Extn
Legal Proceedings Report Classification · 99% confidence The document is very short (1937 chars) and contains the header 'RNS Number : 8725F' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, non-standard regulatory announcement. Since it is a direct, short announcement from the RNS system and doesn't fit the definitions for financial reports (10-K, IR, ER) or specific corporate actions (DIV, DIRS, MANG), it falls best under the general regulatory announcement category, RNS.
2022-11-09 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number' and contains information related to trading procedures on the London Stock Exchange, specifically mentioning a 'Price Monitoring Extension' and referencing RNS as the news service approved by the Financial Conduct Authority (FCA). This is a standard regulatory announcement format used for disseminating timely, non-periodic operational or market-related information that doesn't fit into the major reporting categories (like 10-K, ER, or DIV). Given the context of an RNS number and the nature of the announcement (a trading mechanism update), the most appropriate classification is the general regulatory announcement category.
2022-11-09 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1937 characters) and contains the header 'RNS Number : 8515F' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, time-sensitive operational announcement. This type of general regulatory announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified under the general regulatory filing category, RNS (Regulatory Filings). It is not an announcement of a report itself (RPA), but a direct regulatory update.
2022-11-09 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1920 characters) and its primary content is an announcement regarding a 'Price Monitoring Extension' for a security on the London Stock Exchange, identified by an 'RNS Number'. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates that the document is a general regulatory announcement distributed via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIV, DIRS, or MANG), the most appropriate classification is the general regulatory filing fallback.
2022-11-09 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.